|
|
Professor S. Gail Eckhardt, MD
Professor of Medicine/Oncology, Stapp Harlow Chair in Cancer Research, University of Colorado School of Medicine
Associate Director of Translational Research, University of Colorado Cancer Center
Aurora, United States |
|
|
Biography: |
|
|
S. Gail Eckhardt, MD is a tenured Professor in the Division of Medical Oncology at the University of Colorado School of Medicine where she also holds the Stapp/Harlow Endowed Chair for Cancer Research. |
|
Dr. Eckhardt received her medical degree from the University of Texas Medical Branch in Galveston followed by an internship and residency at the University of Virginia in Charlottesville, VA. After a post-doctoral fellowship at the Scripps Research Foundation, she completed her training in Medical Oncology at the University of California San Diego. In 1999, Dr. Eckhardt joined the faculty of the University of Colorado to initiate and lead the Phase I program and was Division Head of Medical Oncology from 2006-2014. |
|
Dr. Eckhardt has served on numerous committees/study sections, including the ASCO Molecular Oncology Task Force, the ASCO Board of Directors, the FDA Oncology Drugs Advisory Committee, and the NCI Cancer Centers Study Section. She is a member of the NCI Investigational Drug Steering Committee and the NCI Colorectal Cancer Task Force and serves on six External Advisory Boards of NCI designated Cancer Centers. |
|
Dr. Eckhardt is the Principal Investigator on grants involving early clinical trials and colorectal cancer research, has conducted numerous phase I and II clinical trials and has published over 170 manuscripts. Her area of interest is in the preclinical and early clinical development of combinations of molecularly targeted compounds, with a laboratory focus on colorectal cancer. |
|
Session: |
|
|
20th November 2015 (Friday) |
|
16:30 - 17:15 |
|
|
Dr. Cheng Yu Tung Award Lecture in Drug Development |
Challenges and Opportunities of Early Drug Development in the Era of Personalized Medicine |
|